赛尔图因5 (SIRT5) 通过调节线粒体新陈代谢和结质瘤中的突触重塑来抑制瘤生长
Wanjun Tang1, Bo Chen1, Gilberto Ka-Kit Leung1,2
1Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
赛尔图因5 (SIRT5) 通过调节新陈代谢和神经可塑性,在质母细胞瘤中起到瘤抑制作用. 较高的SIRT5水平与质瘤患者的更好的结果相关,这表明治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 赛尔图因5 (SIRT5) 是一种关键的代谢调节剂,在癌症中常常失调.
- 质母细胞瘤表现出有助于瘤进展的代谢变化.
研究的目的:
- 研究SIRT5在质母细胞瘤中的临床病理学意义.
- 阐明SIRT5在质母细胞瘤生长和神经可塑性中的功能作用.
主要方法:
- 对来自质瘤患者的转录组数据的分析.
- 使用质母细胞瘤模型进行体外和体外功能研究.
- 用SIRT5敲击实验来评估细胞生长.
主要成果:
- 增加SIRT5表达与质瘤患者的良好预后相关.
- SIRT5敲击加速了质母细胞瘤细胞的增殖.
- SIRT5影响线粒体新陈代谢和神经质瘤中的突触重塑通路.
结论:
- 在质母细胞瘤中,SIRT5表现出瘤抑制作用.
- SIRT5可以通过调节癌症代谢和神经可塑性来发挥其作用.
- 向SIRT5为质母细胞瘤提供了潜在的治疗策略.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway
